Relative Biological Effectiveness (RBE) in Radiotherapy

Definition

RBE = D_reference / D_test (for identical biological endpoint)

Why RBE Matters

The LET-RBE Relationship

Why high LET = higher RBE (up to a point)

• At ~100 keV/µm LET, the average separation between ionizing events matches the diameter of the DNA double helix (~2 nm)
• This maximizes the probability that a single particle track produces a double-strand break (DSB)
• DSBs from high-LET radiation form clustered, complex "track damage" that is far harder for cells to repair than the isolated strand breaks caused by low-LET X-rays

The "overkill effect"

• At LET above ~100-200 keV/µm, RBE actually decreases
• The radiation deposits far more energy than needed to kill a cell - energy is "wasted"
• Optimal LET for killing (highest RBE): neutrons of a few hundred keV, low-energy protons, alpha particles

Role of oxygen

• Low-LET (X-ray) damage relies heavily on water radiolysis and oxygen to amplify free radical damage - hence the Oxygen Enhancement Ratio (OER) is ~2.5-3 for photons
• High-LET particles cause direct DNA damage that is oxygen-independent
• OER approaches 1.0 for high-LET radiation
• Clinical implication: High-LET particles (carbon ions, neutrons) overcome hypoxia-related radioresistance - valuable in tumors like pancreatic cancer

Factors Affecting RBE

1. Radiation quality (LET) - the dominant determinant
2. Dose and dose per fraction - RBE increases as dose per fraction decreases; for high-LET radiation, RBE is greater with fractionated schedules vs. acute exposure because reference X-rays show more repair sparing with fractionation
3. Biologic endpoint - RBE varies for cell kill, mutation, late effects, etc.
4. Cell/tissue type - repair capacity, cell cycle phase, alpha/beta ratio
5. Dose rate - lower dose rate reduces RBE for low-LET; less so for high-LET

Clinical Application by Radiation Type

Photon and Electron Radiotherapy

• Electrons have a slightly lower RBE (~0.85) vs. photons in the therapeutic range
• Some clinicians recommend a 10-15% increase in total dose for electron beams to compensate, particularly without a bolus
• In practice, photon and electron RBE differences are small enough that they are usually not clinically corrected - Dermatology 2-Volume Set 5e

Proton Therapy

• Protons carry a fixed assumed RBE of 1.1 in virtually all current clinical treatment planning
• This is a simplification - the actual RBE at the distal edge of the Bragg peak has been measured at >5x the assumed value in some studies
• Variable RBE models show 8-24% higher biologic dose to organs at risk (brachial plexus, heart, esophagus) near the beam's end range when RBE 1.1 is not assumed
• The Bragg peak delivers a sharp, localized dose increase then abrupt cutoff - allowing normal tissue sparing beyond the tumor - Campbell Walsh Wein Urology

Carbon Ion Therapy (CIRT)

• RBE is 2-3x or more compared to photons, depending on the tumor volume and planning model
• Two competing RBE models are in clinical use:
  • Modified Microdosimetric Kinetic Model (MKM) - used in Japan
  • Local Effect Model (LEM) - used in European centers (Heidelberg, etc.)
• Differences in models create variability in prescribed doses internationally - a major challenge for comparing outcomes

Neutron Therapy

• Highest RBE of all clinical modalities (~3-10)
• Limited clinical use now due to difficulty controlling dose distribution and late effects

The Bragg Peak and RBE Gradient

• Entrance region (low LET): RBE ≈ 1.0-1.1
• Spread-Out Bragg Peak (SOBP): RBE rises
• Distal edge of Bragg peak (high LET): RBE is highest - potentially 3-5+ for protons, and much higher for carbon ions

RBE in Treatment Planning: Current Debate

• It does not account for LET variation along the beam
• It does not account for dose per fraction, tissue alpha/beta, or cell type
• Variable RBE optimization (LET painting) is an active research area, particularly for head and neck cancers and radioresistant tumors

Summary Table